Anavex Life Sciences Corp (AVXL)

[Anshu2]

To corroborate the intuition that SRPT’s AdCom result will boost the entire biotech market on Monday:

CAPR’s CEO Linda M on Thursday said that “Sarepta’s AdCom meeting will have an impact on the entire biotech industry”…

Seems like a strong statement to make … but I agree and get a feeling that Sarepta’s gene therapy result is a pretty significant or pivotal to the biotech industry and/or FDA’s thinking. It’s likely as big as Adu’s approval process. Big implications—partly because gene therapy is the hottest and greatest innovation right now in health care IMO.

AVXL could get a serious boost on Monday. Likely $10-11 at least, if not $12 plus!